Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 131

1.

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Armstrong AJ, Anand A, Edenbrandt L, Bondesson E, Bjartell A, Widmark A, Sternberg CN, Pili R, Tuvesson H, Nordle Ö, Carducci MA, Morris MJ.

JAMA Oncol. 2018 Jul 1;4(7):944-951. doi: 10.1001/jamaoncol.2018.1093.

PMID:
29799999
2.

Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database.

Nakajima K, Okuda K, Watanabe S, Matsuo S, Kinuya S, Toth K, Edenbrandt L.

Ann Nucl Med. 2018 Jun;32(5):303-310. doi: 10.1007/s12149-018-1247-y. Epub 2018 Mar 7.

3.

Diagnostic accuracy of an artificial neural network compared with statistical quantitation of myocardial perfusion images: a Japanese multicenter study.

Nakajima K, Kudo T, Nakata T, Kiso K, Kasai T, Taniguchi Y, Matsuo S, Momose M, Nakagawa M, Sarai M, Hida S, Tanaka H, Yokoyama K, Okuda K, Edenbrandt L.

Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2280-2289. doi: 10.1007/s00259-017-3834-x. Epub 2017 Sep 26.

4.

Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study.

Reza M, Jones R, Aspegren J, Massard C, Mattila L, Mustonen M, Wollmer P, Trägårdh E, Bondesson E, Edenbrandt L, Fizazi K, Bjartell A.

Eur Urol Focus. 2016 Dec;2(5):547-552. doi: 10.1016/j.euf.2016.01.005. Epub 2016 Feb 3.

5.

Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice.

Reza M, Ohlsson M, Kaboteh R, Anand A, Franck-Lissbrant I, Damber JE, Widmark A, Thellenberg-Karlsson C, Budäus L, Steuber T, Eichenauer T, Wollmer P, Edenbrandt L, Trägårdh E, Bjartell A.

Eur Urol Focus. 2016 Dec;2(5):540-546. doi: 10.1016/j.euf.2016.02.013. Epub 2016 Mar 9.

PMID:
28723520
6.

Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer.

Nakajima K, Edenbrandt L, Mizokami A.

Int J Urol. 2017 Sep;24(9):668-673. doi: 10.1111/iju.13386. Epub 2017 May 26. Review.

7.

3D skeletal uptake of 18F sodium fluoride in PET/CT images is associated with overall survival in patients with prostate cancer.

Lindgren Belal S, Sadik M, Kaboteh R, Hasani N, Enqvist O, Svärm L, Kahl F, Simonsen J, Poulsen MH, Ohlsson M, Høilund-Carlsen PF, Edenbrandt L, Trägårdh E.

EJNMMI Res. 2017 Dec;7(1):15. doi: 10.1186/s13550-017-0264-5. Epub 2017 Feb 16.

8.

A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.

Anand A, Morris MJ, Kaboteh R, Reza M, Trägårdh E, Matsunaga N, Edenbrandt L, Bjartell A, Larson SM, Minarik D.

J Nucl Med. 2016 Dec;57(12):1865-1871. Epub 2016 Jul 21.

9.

Reducing the small-heart effect in pediatric gated myocardial perfusion single-photon emission computed tomography.

Yoneyama H, Nakajima K, Okuda K, Matsuo S, Onoguchi M, Kinuya S, Edenbrandt L.

J Nucl Cardiol. 2017 Aug;24(4):1378-1388. doi: 10.1007/s12350-016-0518-z. Epub 2016 May 19.

PMID:
27197818
10.

Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.

Anand A, Morris MJ, Larson SM, Minarik D, Josefsson A, Helgstrand JT, Oturai PS, Edenbrandt L, Røder MA, Bjartell A.

EJNMMI Res. 2016 Dec;6(1):23. doi: 10.1186/s13550-016-0173-z. Epub 2016 Mar 9.

11.

Evaluation of inter-departmental variability of ejection fraction and cardiac volumes in myocardial perfusion scintigraphy using simulated data.

Trägårdh E, Ljungberg M, Edenbrandt L, Örndahl E, Johansson L, Gustafsson A, Jonsson C, Hagerman J, Riklund K, Minarik D.

EJNMMI Phys. 2015 Dec;2(1):2. doi: 10.1186/s40658-014-0105-9. Epub 2015 Jan 23.

12.

Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.

Anand A, Morris MJ, Kaboteh R, Båth L, Sadik M, Gjertsson P, Lomsky M, Edenbrandt L, Minarik D, Bjartell A.

J Nucl Med. 2016 Jan;57(1):41-5. doi: 10.2967/jnumed.115.160085. Epub 2015 Aug 27.

13.

Perfusion vector-a new method to quantify myocardial perfusion scintigraphy images: a simulation study with validation in patients.

Minarik D, Senneby M, Wollmer P, Mansten A, Sjöstrand K, Edenbrandt L, Trägårdh E.

EJNMMI Res. 2015 Dec;5(1):121. doi: 10.1186/s13550-015-0121-3. Epub 2015 Aug 14.

14.

Bone Scan Index predicts outcome in patients with metastatic hormone-sensitive prostate cancer.

Poulsen MH, Rasmussen J, Edenbrandt L, Høilund-Carlsen PF, Gerke O, Johansen A, Lund L.

BJU Int. 2016 May;117(5):748-53. doi: 10.1111/bju.13160. Epub 2015 Jun 13.

15.

Diagnostic Performance of Artificial Neural Network for Detecting Ischemia in Myocardial Perfusion Imaging.

Nakajima K, Matsuo S, Wakabayashi H, Yokoyama K, Bunko H, Okuda K, Kinuya S, Nyström K, Edenbrandt L.

Circ J. 2015;79(7):1549-56. doi: 10.1253/circj.CJ-15-0079. Epub 2015 Apr 3.

16.

Reporting nuclear cardiology: a joint position paper by the European Association of Nuclear Medicine (EANM) and the European Association of Cardiovascular Imaging (EACVI).

Trägårdh E, Hesse B, Knuuti J, Flotats A, Kaufmann PA, Kitsiou A, Hacker M, Verberne HJ, Edenbrandt L, Delgado V, Donal E, Edvardsen T, Galderisi M, Habib G, Lancellotti P, Nieman K, Rosenhek R; EACVI, Agostini D, Gimelli A, Lindner O, Slart R, Ubleis C; EANM.

Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):272-9. doi: 10.1093/ehjci/jeu304. Epub 2015 Jan 23. Review.

17.

Computerized decision making in myocardial perfusion SPECT: The new era in nuclear cardiology?

Trägårdh E, Carlsson M, Edenbrandt L.

J Nucl Cardiol. 2015 Oct;22(5):885-7. doi: 10.1007/s12350-014-0041-z. Epub 2014 Dec 11. No abstract available.

PMID:
25500801
18.

Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.

Reza M, Bjartell A, Ohlsson M, Kaboteh R, Wollmer P, Edenbrandt L, Trägårdh E.

EJNMMI Res. 2014 Oct 17;4:58. doi: 10.1186/s13550-014-0058-y. eCollection 2014.

19.

The accuracy of quantitative parameters in (99m) Tc-MAG3 dynamic renography: a national audit based on virtual image data.

Brolin G, Edenbrandt L, Granerus G, Olsson A, Afzelius D, Gustafsson A, Jonsson C, Hagerman J, Johansson L, Riklund K, Ljungberg M.

Clin Physiol Funct Imaging. 2016 Mar;36(2):146-54. doi: 10.1111/cpf.12208. Epub 2014 Oct 28.

PMID:
25348641
20.

Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).

Armstrong AJ, Kaboteh R, Carducci MA, Damber JE, Stadler WM, Hansen M, Edenbrandt L, Forsberg G, Nordle Ö, Pili R, Morris MJ.

Urol Oncol. 2014 Nov;32(8):1308-16. doi: 10.1016/j.urolonc.2014.08.006. Epub 2014 Sep 16.

Supplemental Content

Loading ...
Support Center